Milan, Italy

Gianfranco Pala

This inventor holds 1 USPTO granted patent. Top assignee: Istituto De Angeli. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianfranco Pala. Retrieved from https://idiyas.com/inventor/gianfranco-pala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gianfranco Pala: Innovator in Pharmacology

Introduction

Gianfranco Pala is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmacology through his innovative work. His research focuses on compounds that have therapeutic applications, particularly in pain relief and inflammation.

Latest Patents

Gianfranco Pala holds a patent for a compound known as (3-Methyl-2-butenyl)propanedioic acid mono (1,2-diphenylhydrazide). This compound, along with its non-toxic, pharmacologically acceptable salts, is recognized for its usefulness as an analgesic, antipyretic, and anti-rheumatic agent. His work in this area highlights the potential for new treatments in managing pain and inflammation.

Career Highlights

Gianfranco Pala is associated with Istituto De Angeli S.p.a., where he continues to develop and refine his innovative ideas. His dedication to research and development has positioned him as a key figure in his field. With a patent portfolio that includes 1 patent, he demonstrates a commitment to advancing medical science.

Collaborations

Gianfranco collaborates with Enzo Cereda, working together to explore new avenues in pharmacological research. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Gianfranco Pala's contributions to pharmacology through his patented inventions are noteworthy. His work not only enhances our understanding of therapeutic compounds but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…